PDR MEMBER LOGIN:
  • PDR Search

    Required field
  • PDR Drug Communications are designed to improve the speed and efficacy of the delivery of PDR Drug Alerts, Recalls and Approvals to physicians, prescribers, and their staff.

    Below are the PDR Drug Communications that have been issued by PDR Network. To view the communication details, click on the Medication name.

    If you have trouble accessing Alert details, click to get the latest version of the free Adobe Acrobat Reader software for your computer.

    Filter results by:

    Results 1-20 of 50

    September 03, 2014 Drug Alert: Important Drug Information

    ER/LA Opioid Analgesics

    Various

    August 13, 2014 Drug Alert: FDA-REQUIRED REMS SAFETY INFORMATION

    Afrezza® (insulin human) Inhalation Powder

    MannKind Corporation

    August 12, 2014 Drug Alert: FDA-REQUIRED REMS SAFETY INFORMATION

    Symlin® (pramlintide acetate) injection

    AstraZeneca

    May 13, 2014 Drug Alert: Important Drug Warning

    Xeljanz® (tofacitinib)

    Pfizer Inc

    April 14, 2014 Drug Alert: Important Prescribing Information

    JEVTANA® (cabazitaxel)

    sanofi-aventis U.S.

    March 31, 2014 Drug Approval:

    Aptiom® (eslicarbazepine acetate)

    Sunovion Pharmaceuticals

    March 24, 2014 Drug Alert: Important Drug Warning

    Zelboraf® (vemurafenib)

    Genentech

    February 14, 2014 Drug Alert: Important Drug Warning

    GAZYVA(TM) (obinutuzumab)

    Genentech

    February 13, 2014 Drug Approval:

    NEXAVAR® (sorafenib)

    Bayer

    January 29, 2014 Drug Alert: Important Drug Warning

    XELODA® (capecitabine)

    Genentech

    January 07, 2014 Drug Alert: FDA-REQUIRED REMS SAFETY INFORMATION

    Iclusig® (ponatinib)

    ARIAD Pharmaceuticals

    December 30, 2013 Drug Alert: Important Drug Warning

    ADASUVE® (loxapine)

    Teva

    November 11, 2013 Drug Alert: Important Drug Warning

    Xeljanz® (tofacitinib)

    Pfizer Inc

    November 01, 2013 Drug Alert: Important Drug Warning

    Rituxan® (rituximab)

    Genentech

    October 29, 2013 Drug Alert: Important Prescribing Information

    ACTEMRA® (tocilizumab)

    Genentech

    September 20, 2013 Drug Alert: Important Drug Warning

    Gilenya® (fingolimod)

    Novartis Pharmaceuticals Corporation

    September 10, 2013 Drug Approval:

    Latuda (lurasidone HCl)

    Sunovion Pharmaceuticals

    August 12, 2013 Drug Alert: Important Drug Warning

    Zelboraf® (vemurafenib)

    Genentech

    July 26, 2013 Drug Alert: Important Drug Warning

    ASTAGRAF XL(TM) (tacrolimus extended-release capsules)

    Astellas Pharma

    July 19, 2013 Drug Alert: Important Drug Warning

    Brilinta® (ticagrelor)

    AstraZeneca

    Results 1-20 of 50